Ligand Pharmaceuticals Inc (LGND) returns
Ligand Pharmaceuticals returns over 10 years
$1,000 invested in Ligand Pharmaceuticals ten years ago was worth $3,395 at the close on October 30, 2026, with dividends reinvested: an average return of 13.0% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +3.3% | — | $1,033 | -0.9% |
| 3 months | +8.9% | — | $1,089 | +2.1% |
| Year to date | +70.7% | — | $1,707 | +11.7% |
| 1 year | +72.5% | — | $1,725 | +12.4% |
| 3 years | +534.5% | +85.1% | $6,345 | +88.5% |
| 5 years | +121.2% | +17.2% | $2,212 | +76.0% |
| 10 years | +239.5% | +13.0% | $3,395 | +316.6% |
Ligand Pharmaceuticals return by calendar year
| Year | LGND | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +70.7% | +11.7% | +59.0% |
| 2025 | +76.5% | +17.7% | +58.7% |
| 2024 | +50.0% | +24.9% | +25.1% |
| 2023 | +6.9% | +26.2% | -19.3% |
| 2022 | -56.8% | -18.2% | -38.6% |
| 2021 | +55.3% | +28.7% | +26.6% |
| 2020 | -4.6% | +18.4% | -23.0% |
| 2019 | -23.1% | +31.2% | -54.4% |
| 2018 | -0.9% | -4.6% | +3.7% |
| 2017 | +34.8% | +21.7% | +13.1% |
| 2016 | -6.3% | +12.0% | -18.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: LGND financials · LGND valuation
No forecast, no recommendation. This page describes Ligand Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.